Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).

News & Events

: Tonix In The News

Home
News & Events
Tonix In The News

Tonix In The News

Dr. Seth Lederman interviewed on Nobel Laureate Economist on Vaccine Equity

Bloomberg |

March 23, 2021

Positive Phase 3 Efficacy Data Bolsters Tonix Pharmaceuticals' Expectations For Phase 3 Confirmatory Trial In Fibromyalgia

Benzinga |

March 19, 2021

Tonix Pharmaceuticals CEO Believes That Additional COVID-19 Vaccine Research Is Still Needed

Benzinga |

February 2, 2021

Dr. Seth Lederman interviewed on ABC FOX Montana to discuss highlights of Tonix’s planned vaccine manufacturing facility in Hamilton, MT

ABC FOX Montana |

January 6, 2021

Dr. Seth Lederman interviewed on Contagion Live to discuss its COVID-19 vaccine in development

Contagion Live |

December 4, 2020

Dr. Seth Lederman’s interview with the Science Writer for Technology Networks

Technology Networks |

April 7, 2020

Developing Covid-19 Vaccines at Pandemic Speed

New England Journal of Medicine |

March 30, 2020

Updated on April 6, 2020.

We need more than awareness to defeat the epidemic of veteran suicides

Washington Examiner |

September 23, 2019

Tonix Pharmaceuticals doses first patient in Phase 1 trial to treat PTSD

Proactive |

September 5, 2019

Military-related PTSD: Our year to act